Management of acute pancreatitis with fluid management in detail with reference to standard textbook

Reading File

Finding Sources

Searching PubMed

"acute pancreatitis" AND "fluid resuscitation"

Reading File

Finding Sources

Reading File

Finding Sources

Reading File

I now have comprehensive content from multiple textbooks. Let me compile the detailed, well-referenced answer.

Management of Acute Pancreatitis - With Emphasis on Fluid Management

Overview

Acute pancreatitis (AP) spans a wide clinical spectrum - from a mild, self-limited illness (85-90% of cases resolve within 3-7 days without organ failure) to severe, life-threatening disease with multiorgan failure and mortality exceeding 50%. Management is primarily supportive, and fluid resuscitation is the single most important early intervention.

Harrison's Principles of Internal Medicine 22E (2025), Ch. 359

Classification of Severity

Understanding severity guides fluid strategy and monitoring intensity.

Classification System	Categories
Revised Atlanta Classification (RAC)	Mild (no organ failure/local complications), Moderately Severe (transient organ failure or local complications), Severe (persistent organ failure >48h)
Determinant-Based Classification (DBC)	Mild, Moderate, Severe, Critical (persistent organ failure + infected necrosis)

Organ failure is scored using the Marshall or SOFA scoring systems, targeting the cardiovascular, respiratory, and renal systems. Multiple organ failure = 2+ organs scoring 2+ points.

Schwartz's Principles of Surgery, 11E, Ch. 33

Pathophysiology Underpinning Fluid Loss

In AP, a massive systemic inflammatory response (SIRS) drives:

Third-space fluid shifts - retroperitoneal edema, ascites, ileus
Capillary leak syndrome - increased vascular permeability
Vomiting and reduced oral intake
Splanchnic vasodilation

These result in intravascular volume depletion, leading to hemoconcentration, renal hypoperfusion, and risk of pancreatic microcirculatory failure - which perpetuates and worsens necrosis. Mesenteric lymph containing proinflammatory cytokines bypasses the liver and contributes to systemic organ failure.

Schwartz's Principles of Surgery, 11E, p. 1471
Current Surgical Therapy, 14E

Initial Assessment & Monitoring

In the Emergency Department (first 4-6 hours)

All patients with confirmed AP should:

Be made NPO to minimize pancreatic stimulation
Receive IV narcotic analgesics for pain control
Receive supplemental oxygen as needed
Have severity assessed immediately

Monitoring targets (non-invasive):

Heart rate (target <100 bpm)
Mean arterial pressure (MAP)
Urine output (target >0.5 mL/kg/hour)
Oxygen saturation

Serial bedside evaluations should occur every 6-8 hours to assess vital signs, oxygen saturation, and clinical examination.

Harrison's 22E, Ch. 359; Current Surgical Therapy, 14E

In Severe AP - Invasive Monitoring

Patients with severe AP benefit from intensive monitoring targeting:

Central venous pressure (CVP): 8-12 mmHg
Mixed venous oxygen saturation: ≥70%

This approach has been shown to result in fewer hospital days, less ventilator time, reduced organ failure, and lower mortality. There should be a low threshold for ICU transfer in severe disease.

Current Surgical Therapy, 14E, p. 606; Bailey & Love, 28E, Table 72.4

Key Laboratory Markers Guiding Fluid Therapy

Parameter	Significance
BUN (blood urea nitrogen)	Rising BUN = inadequate hydration AND higher in-hospital mortality. A falling BUN in first 12-24h confirms adequate resuscitation
Hematocrit	Elevated = hemoconcentration (inadequate resuscitation). Falling hematocrit in first 12-24h confirms adequate volume
CRP >100 mg/L	Marker of severity (more useful at 24-48h)
Serum creatinine >2.0 mg/dL	Renal organ failure criterion
PaO2 <60 mmHg	Pulmonary organ failure criterion

Recommended monitoring frequency: hematocrit and BUN every 8-12 hours for the first 24-48 hours.

Harrison's 22E, Markers of Severity section

Fluid Resuscitation - The Core Intervention

Rationale

"Fluid therapy to restore and maintain circulating blood volume is the most important intervention in the early management of acute pancreatitis."

Schwartz's Principles of Surgery, 11E

1. Choice of Fluid

Lactated Ringer's solution (LR) is the preferred crystalloid over normal saline (NS).

Evidence and rationale:

LR reduces systemic inflammation - demonstrated by lower C-reactive protein levels from admission compared to NS
LR is more physiologically balanced; NS can cause hyperchloremic metabolic acidosis
LR may exert anti-inflammatory effects - the lactate component is metabolized to bicarbonate and may modulate macrophage activation
Rosen's Emergency Medicine (10E): "Lactated Ringers is preferred over normal saline because it is more physiologic and may provide antiinflammatory effects"

Clinical note (2024-2025 meta-analyses): Two recent systematic reviews and meta-analyses confirm this preference. Wang et al. (PMID 38101616, Gastroenterol Hepatol, Oct 2024) and Zhao et al. (PMID 40085761, Int J Surg, May 2025) both confirm LR is superior to NS in reducing progression to moderate-to-severe AP and decreasing systemic inflammation.

Colloids (albumin, hydroxyethyl starch): Not recommended as first-line. A 2026 systematic review (PMID 42107597) found insufficient evidence for early albumin infusion in moderate-to-severe AP to make routine recommendations.

Harrison's 22E; Schwartz's 11E; Current Surgical Therapy, 14E; Rosen's Emergency Medicine

2. Rate and Volume - Aggressive vs. Goal-Directed

Traditional "Aggressive" Strategy

Historically promoted based on the severe fluid losses:

Initial bolus: 15-20 mL/kg (approximately 1,050-1,400 mL)
Maintenance: 2-3 mL/kg/hour (200-250 mL/h)

Current Surgical Therapy, 14E recommends initial goal-directed therapy of 5-10 mL/kg/h, titrated to resuscitation targets.

Recent Evidence - Moderate Strategy

A landmark randomized controlled trial (referenced in Harrison's 22E) demonstrated that the aggressive hydration strategy is associated with an increased risk of fluid overload without improvement in clinical outcomes compared to a more moderate strategy:

Moderate bolus: 10 mL/kg
Maintenance: 1.5 mL/kg/hour

This reflects a paradigm shift from "more is better" toward goal-directed, titrated resuscitation.

Harrison's Principles of Internal Medicine 22E (2025)

Schwartz's Perspective

Schwartz's cautions that while proponents of vigorous fluid therapy (5-10 mL/kg/h, especially in the first 24 hours) exist, it is "probably best to resuscitate with a balanced crystalloid and aim to restore normal blood volume, blood pressure, and urine output" - with particular caution in elderly patients and those with cardiac or renal disease.

Schwartz's Principles of Surgery, 11E, p. 1472

3. Monitoring Response to Fluid Therapy

A targeted resuscitation strategy is key. Continue fluid resuscitation until:

Goal	Target
Urine output	>0.5 mL/kg/hour
Heart rate	<100 bpm
MAP	>65 mmHg
CVP (severe AP)	8-12 mmHg
Mixed venous O2 sat (severe)	≥70%
Hematocrit	Falling trend (normalization)
BUN	Falling or stable

"A decrease in hematocrit and BUN during the first 12-24h is strong evidence that an adequate volume of fluids is being administered."

Harrison's Principles of Internal Medicine 22E (2025)

4. Risk of Fluid Overload

Over-resuscitation is a recognized complication of aggressive fluid therapy. Clinical signs include:

Tachypnea
Hypoxia (worsening respiratory failure)
Lower extremity edema
Pleural effusions on chest radiograph
Abdominal compartment syndrome (ACS) - a serious late complication

Patients should be monitored for ACS (intra-abdominal pressure >20 mmHg with new organ failure) in the setting of massive fluid resuscitation.

Once the initial hypovolemia has resolved, patients may benefit from cautious diuresis to prevent ongoing fluid accumulation.

Special caution in: cardiac disease, renal disease, elderly patients.

Current Surgical Therapy, 14E; Harrison's 22E; Schwartz's 11E

5. NPO Status vs. Early Oral Intake

The traditional practice of keeping all pancreatitis patients NPO until pain and lipase normalize has been abandoned:

Mild-moderate AP: Oral feeding can be started within 24 hours of admission, even if lipase has not normalized. A low-fat or normal solid diet can be started directly, without a liquid/soft diet trial.
Severe AP or intolerance of oral diet: Nasogastric (NG) or nasojejunal (NJ) tube feeds once hemodynamically stable.
Current Surgical Therapy, 14E

Nutritional Support

Nutritional support is a key pillar of AP management and distinct from fluid resuscitation.

Enteral Nutrition (Preferred)

Early enteral nutrition (EN) is the mainstay:

Benefits: Maintains gut mucosal integrity, stabilizes the gut microbiome, decreases infected pancreatic necrosis, reduces multiorgan failure, shortens length of stay
Timing: Within 24-72 hours. Initiation within first 24h is not superior to starting at 72h, but delay beyond 72h risks ileus
Route: Nasogastric feeding is acceptable; nasojejunal if gastric intolerance occurs. RCTs show no significant difference in outcomes between gastric and jejunal feeding in severe AP
If NG tube feeding is not tolerated over 48-72 hours, advance to nasojejunal tube by endoscopy or fluoroscopy
Formula: Standard polymeric formulas are as effective as elemental or immune-enhancing formulas (no evidence of superiority)

"It is no longer acceptable to 'rest the pancreas' by avoiding enteral nutrition."

Schwartz's Principles of Surgery, 11E

Parenteral Nutrition (Reserve)

Total parenteral nutrition (TPN) should be reserved for patients who:

Cannot tolerate oral or nasoenteric feeding within 5-7 days of admission
TPN is associated with increased risk of infected necrosis, multiorgan failure, and is more expensive
Schwartz's 11E; Current Surgical Therapy, 14E; Yamada's Textbook of Gastroenterology, 7E

Other Key Management Components

Analgesia

IV opioid analgesics are the standard of care for pain control
No one opioid agent is proven superior to another
Patient-controlled analgesia (PCA) may be used in severe cases

Antibiotics

Prophylactic antibiotics are NOT indicated - even in severe AP or with sterile peripancreatic necrosis
Multiple RCTs show no benefit of prophylaxis; risks include fungal superinfection and selection of drug-resistant organisms
Antibiotics ARE indicated when:
- Infected pancreatic necrosis is confirmed (CT showing gas bubbles in collection, or positive FNA culture)
- Concomitant cholangitis or biliary sepsis
- Other clear source of infection
Preferred agents for infected necrosis: Carbapenems (e.g., imipenem) - best pancreatic tissue penetration
Current Surgical Therapy, 14E; Bailey & Love, 28E

ERCP

Routine ERCP is NOT indicated for all gallstone pancreatitis
Indications: Ascending cholangitis, biliary obstruction, impacted common bile duct stone
Timing: Within 24-48 hours for cholangitis; within 72 hours for severe gallstone pancreatitis

Cholecystectomy

Essential to prevent recurrent gallstone pancreatitis
Index cholecystectomy (same admission) is safe and preferred in mild AP
Delayed if local pancreatic complications are present

Summary Algorithm: Fluid Management in Acute Pancreatitis

DIAGNOSIS CONFIRMED
        │
        ▼
Emergency Dept: NPO + IV Access + O2
        │
        ▼
Initial Fluid Bolus: LR 10-15 mL/kg
        │
        ▼
Reassess every 6-8h:
  - Urine output >0.5 mL/kg/h?
  - HR <100? MAP >65?
  - BUN/Hematocrit trending down?
        │
      YES ──────────────────────→ Continue LR at 1.5-3 mL/kg/h
        │                          Monitor for fluid overload
       NO
        │
        ▼
Persistent tachycardia/hypotension/oliguria?
→ Intensify monitoring (CVP, MVO2)
→ Consider ICU transfer
→ Target CVP 8-12 mmHg, MVO2 ≥70%
→ Repeat LR bolus if needed
        │
        ▼
Watch for OVERLOAD:
Tachypnea, hypoxia, edema, ACS
→ Diurese once euvolemic

Early Management Checklist (Bailey & Love, 28E, Table 72.4)

Action
Admission to HDU/ICU (severe cases)
Analgesia (IV opioids)
Aggressive fluid rehydration (LR preferred)
Supplemental oxygen
Invasive monitoring: CVP, urine output, blood gases (severe)
Frequent labs: FBC, LFTs, renal function, clotting, calcium, glucose
Nasogastric drainage if needed (initially)
Antibiotics only if cholangitis/infection suspected
CT scan if organ failure, deterioration, or signs of sepsis develop
ERCP within 72h for severe gallstone pancreatitis / cholangitis
Supportive therapy for organ failure (inotropes, ventilation, haemofiltration)
Early enteral nutrition when hemodynamically stable

References (Standard Textbooks)

Harrison's Principles of Internal Medicine, 22nd Edition (2025, McGraw Hill) - Ch. 359: Acute Pancreatitis. Fluid resuscitation protocols, BUN/hematocrit monitoring, BISAP severity scoring.
Schwartz's Principles of Surgery, 11th Edition - Ch. 33: Management of Acute Pancreatitis. Fluid therapy, nutritional support, antibiotic prophylaxis, ERCP, cholecystectomy.
Current Surgical Therapy, 14th Edition - Fluid resuscitation targets, goal-directed therapy (5-10 mL/kg/h), monitored care, nutrition, antibiotics.
Bailey & Love's Short Practice of Surgery, 28th Edition - Table 72.4: Early management checklist for severe AP; systemic complications.
Rosen's Emergency Medicine: Concepts and Clinical Practice - Key concepts: LR vs. NS, supportive treatment principles.
Yamada's Textbook of Gastroenterology, 7th Edition - Enteral nutrition in AP; Cochrane review data on nasoenteric tube feeding.

Recent Supporting Evidence (PubMed)

Wang Z et al. (2024). LR vs NS meta-analysis in acute pancreatitis. Gastroenterol Hepatol. PMID: 38101616
Zhao T et al. (2025). LR vs saline for preventing moderate-to-severe AP. Int J Surg. PMID: 40085761
Sunkesula V et al. (2026). Early albumin infusion in moderate-to-severe AP - systematic review. Clin Res Hepatol Gastroenterol. PMID: 42107597

Grading of acute pancreatitis

Finding Sources

Reading File

Finding Sources

Reading File

Finding Sources

Reading File

I now have all the data needed for a thorough, well-referenced answer. Let me compile it.

Grading of Acute Pancreatitis

Grading acute pancreatitis serves two purposes: (1) identifying patients at risk of severe disease who require ICU-level care, and (2) guiding management decisions including fluid resuscitation, ERCP, nutrition, and antibiotic use. Multiple clinical, biochemical, and radiological systems exist.

I. Morphological Classification (2012 Revised Atlanta Classification)

The 2012 Revised Atlanta Classification (RAC) is the current international standard, endorsed by the International Association of Pancreatology. It defines three severity grades based on organ failure and local/systemic complications:

Grade	Organ Failure	Complications	Mortality
Mild	Absent	Absent	Very rare (<5%)
Moderately Severe	Transient (<48 h)	Present, without persistent organ failure	Low
Severe	Persistent (>48 h)	Present	High (36-50%); extremely high with infected necrosis

Key definitions:

Organ failure = Modified Marshall Score ≥2 for any of: respiratory, cardiovascular, or renal systems
Transient organ failure = resolves within 48 hours
Persistent organ failure = lasts >48 hours (defines severe disease)
Local complications = Acute peripancreatic fluid collection (APFC), pancreatic pseudocyst, acute necrotic collection (ANC), walled-off necrosis (WON)
Systemic complications = exacerbation of pre-existing comorbidity (e.g., COPD, CHF)

Important: Final severity grade evolves throughout the disease course. Reevaluation should occur at 24 hours, 48 hours, 7 days, and weekly thereafter.

Rosen's Emergency Medicine, Box 77.4; Current Surgical Therapy, 14E, Table 1; Bailey & Love, 28E; Sabiston, 21E

II. Clinical Scoring Systems

1. Ranson's Criteria (1974, modified 1982)

The oldest and most widely known scoring system, designed for the first 48 hours. Two versions exist: one for non-gallstone (alcoholic) pancreatitis, one for gallstone pancreatitis.

Ranson's Criteria - Non-Gallstone Pancreatitis

At Admission	Within 48 Hours
Age >55 years	Hematocrit fall >10 points
WBC >16,000/mm³	BUN rise >5 mg/dL
Blood glucose >200 mg/dL	Serum calcium <8 mg/dL
Serum LDH >350 IU/L	Arterial PO₂ <60 mmHg
Serum AST >250 U/dL	Base deficit >4 mEq/L
	Estimated fluid sequestration >6 L

Ranson's Criteria - Gallstone Pancreatitis (Modified)

At Admission	Within 48 Hours
Age >70 years	Hematocrit fall >10 points
WBC >18,000/mm³	BUN rise >2 mg/dL
Blood glucose >220 mg/dL	Serum calcium <8 mg/dL
Serum LDH >400 IU/L	Base deficit >5 mEq/L
Serum AST >250 U/dL	Estimated fluid sequestration >4 L

Interpretation (Mortality correlation):

Score	Mortality
0-2	<1%
3-4	15%
5-6	40%
>6	~100%

Score ≥3 = Severe pancreatitis

Performance:

Positive predictive value (PPV): 50%
Negative predictive value (NPV): 90%
Primarily used to rule out severe pancreatitis (high NPV)

Limitations:

Cannot be completed until 48 hours after admission
Complex (11 parameters)
Not originally designed to predict severity
Falling out of favor due to complexity and lack of specificity
Schwartz's Principles of Surgery, 11E, Table 33-7; Yamada's Gastroenterology, 7E, Table 74.4; Sabiston, 21E, Box 92.1 & 92.2; Bailey & Love, 28E, Table 72.3

2. Glasgow (Imrie) Score

A simplified 8-criteria system popular in the United Kingdom, calculated within 48 hours. Score ≥3 indicates severe disease.

Criterion	Threshold
Age	>55 years
White blood cell count	>15 × 10⁹/L
Blood glucose	>10 mmol/L (no history of DM)
LDH or AST	LDH >600 U/L or AST >200 U/L
Serum urea	>16 mmol/L (no response to IV fluids)
Arterial PaO₂	<8 kPa (60 mmHg)
Serum calcium	<2.0 mmol/L
Serum albumin	<32 g/L

Score ≥3 = Severe pancreatitis

Note: The Glasgow score differs from Ranson's in including albumin and serum urea, and omitting base deficit, fluid sequestration, and hematocrit fall.

Sleisenger & Fordtran's GI and Liver Disease; Bailey & Love, 28E, Table 72.3

3. APACHE II Score (Acute Physiology and Chronic Health Evaluation II)

A general ICU severity score based on:

12 acute physiologic variables (each scored 0-4 points, with exceptions for renal and neurological impairment)
Age points (up to 6 points)
Chronic health status points

APACHE II score ≥8 = Severe pancreatitis (PPV 43%, NPV 89%)

Advantages:

Can be calculated on admission and repeated at any time
Dynamically tracks disease progression

Disadvantages:

Complex (15 variables)
Not specific to pancreatitis
Age-weighted (easily upgrades severity in elderly patients)
Low sensitivity and PPV (<36%) on admission alone; better predictive accuracy after 48 hours

"Apache II has stood the test of time and no score is convincingly superior to it, but it has the drawback of being cumbersome."

Sleisenger & Fordtran's GI and Liver Disease

Yamada's Gastroenterology, 7E, Table 74.5; Sabiston, 21E; Sleisenger & Fordtran's

4. BISAP Score (Bedside Index of Severity in Acute Pancreatitis, 2008)

A simple 5-variable score calculable within 24 hours of admission - the most applicable system in the emergency department.

Variable	Criterion	Points
B - BUN	>25 mg/dL	1
I - Impaired mental status	Glasgow Coma Scale <15	1
S - SIRS	≥2 SIRS criteria present	1
A - Age	>60 years	1
P - Pleural effusion	Present on imaging	1
Total		/5

BISAP Score Interpretation:

Score	Mortality Risk
0	<1%
1-2	Low
3-5	Substantially increased
4-5	7- to 12-fold increased risk of organ failure

Score ≥3 = High risk for severe disease, increased mortality

Performance:

BISAP ≥3: significantly increased risk of in-hospital mortality
BISAP ≥4-5: strongly associated with organ failure and pancreatic necrosis
Compared to Ranson and APACHE II: similar predictive accuracy but simpler and calculable earlier
Harrison's 22E; Rosen's EM; Sabiston, 21E; Sleisenger & Fordtran's; Schwartz's 11E

5. SIRS Criteria - Current Recommended Bedside Tool

Many professional societies (IAP/APA) now recommend SIRS as the fast, inexpensive, reliable first-line severity assessment tool at admission, as it has proven equivalent or superior to more complex scoring systems.

SIRS = 2 or more of:

Criterion	Threshold
Temperature	>38.3°C or <36°C
Heart rate	>90 beats/min
Respiratory rate	>20/min or PaCO₂ <32 mmHg
White blood cell count	>12,000/mm³, <4,000/mm³, or >10% band forms

SIRS and Mortality:

SIRS status	Mortality
Never met SIRS criteria	~0%
Transient SIRS (resolves)	~8%
Persistent SIRS (>48 h)	~25%

If SIRS is absent at 24 hours, the patient is unlikely to develop organ failure or necrosis.

Sabiston, 21E, Box 92.3; Current Surgical Therapy, 14E; Sleisenger & Fordtran's

6. HAPS (Harmless Acute Pancreatitis Score)

A rapid 3-parameter score designed to identify mild disease at presentation with high specificity.

Parameter	Criterion
Peritonism	Absent (no rebound tenderness/guarding)
Serum creatinine	Normal
Hematocrit	Normal

All 3 normal = likely harmless (mild) course
Specificity for mild disease: 97% (but not sensitive - cannot rule out severe disease)
Useful for early discharge planning in clearly mild cases
Schwartz's 11E; Rosen's EM

III. Radiological Grading

Balthazar CT Grading System (Original CTSI)

Based on contrast-enhanced CT (CECT), assessing both pancreatic inflammation (grades A-E) and degree of necrosis.

Balthazar Grade (Inflammation):

Grade	CT Appearance	Points
A	Normal pancreas	0
B	Focal or diffuse pancreatic enlargement with contour irregularities	1
C	Grade B + peripancreatic inflammation	2
D	Grade C + single peripancreatic fluid collection	3
E	Grade C + ≥2 fluid collections or gas in/adjacent to pancreas	4

Necrosis Score:

Degree of Necrosis	Points
None	0
≤30% (up to one-third)	2
30-50% (one-third to one-half)	4
>50% (more than one-half)	6

CT Severity Index (CTSI) = Balthazar Grade Points + Necrosis Score (maximum 10)

CTSI Outcomes:

Score	Mortality	Morbidity
0-3	3%	8%
4-6	6%	35%
7-10	17%	92%

CTSI ≥4 = High risk for severe disease (correlates with local complications, especially pseudocysts and abscesses)

Mortality rate among Balthazar grade D/E was 13.5% vs 0% for grades A-C (Balthazar, Radiology 1990).

Sabiston, 21E, Table 92.2; Sleisenger & Fordtran's, Table 58.1; Yamada's 7E; Sabiston

Modified CTSI (MCTSI)

A simplified revision that better correlates with patient outcome by adding extrapancreatic complications as a separate category.

Feature	Points
Pancreatic Inflammation:
Normal pancreas	0
Intrinsic abnormalities ± peripancreatic fat changes	2
Pancreatic/peripancreatic fluid collection or peripancreatic fat necrosis	4
Pancreatic Necrosis:
None	0
≤30%	2
>30%	4
Extrapancreatic Complications (≥1 of: pleural effusion, ascites, vascular complications, GI tract involvement)	2

MCTSI Severity Classification:

Score	Severity
0-2	Mild
4-6	Moderate
8-10	Severe

MCTSI ≥4 = High risk for severe disease

CT scoring alone does not supersede clinical scoring systems (BISAP, Ranson's, APACHE-II) for identifying severe pancreatitis - the combination is most informative.

Grainger & Allison's Diagnostic Radiology, Table 25.1; Rosen's EM

Timing of CT in Acute Pancreatitis

Not required in all patients - especially mild presentations where clinical/biochemical criteria suffice
Optimal timing: 48-72 hours after symptom onset (early CT may underestimate necrosis, which takes 2-3 days to fully develop)
Indications for CT:
- Diagnostic uncertainty
- Severe disease or organ failure
- Clinical deterioration despite treatment
- Suspected local complications (necrosis, abscess, pseudocyst)
- Gas bubbles in a collection (diagnostic for infected necrosis)
- Suspected bowel ischemia or bleeding
Bailey & Love, 28E; Grainger & Allison's Diagnostic Radiology

IV. Single Biochemical Markers

Marker	Threshold for Severity	Notes
C-reactive protein (CRP)	≥150 mg/L at 48-72 h	Gold standard biochemical marker; peaks 48-72h after onset; not useful on admission
Hematocrit	Elevated (hemoconcentration)	Associated with necrosis; falling value confirms adequate resuscitation
BUN	Rising BUN	Linked to inadequate hydration and higher mortality
Procalcitonin	Elevated	Predictor of severe AP; also useful for suspected infected necrosis
Serum calcium	<2.0 mmol/L	Marker of severity in Ranson/Glasgow systems
IL-6, IL-1, Elastase	Elevated	Correlate with severity; limited by cost and availability

Sabiston, 21E; Rosen's EM; Schwartz's 11E

V. Comparative Summary of Scoring Systems

Feature	Ranson	Glasgow	APACHE II	BISAP	SIRS	CTSI/MCTSI
Number of variables	11	8	15	5	4	CT-based
Timing of completion	48 h	48 h	On admission + dynamic	24 h	On admission + dynamic	48-72 h (optimal)
Specificity to AP	Yes	Yes	No	No	No	Yes
Severe if score ≥	3	3	8	3	Persistent >48h	CTSI ≥4 or 7-10
PPV	50%	Similar	43%	Good	Moderate	54%
NPV	90%	High	89%	High	High	High
Ease of use	Moderate	Moderate	Complex	Simple	Very simple	Requires CT
Best use	Predicting outcome at 48h	Predicting outcome at 48h	ICU monitoring	ED triage within 24h	Rapid bedside triage	Assessing local complications

VI. Organ Failure Scoring - Modified Marshall Score

Used as the reference standard in the 2012 RAC to define organ failure:

System	Score 2 (defines organ failure)
Respiratory	PaO₂/FiO₂ <300
Cardiovascular	Systolic BP <90 mmHg (not fluid-responsive)
Renal	Serum creatinine >1.9 mg/dL

A Modified Marshall Score ≥2 in any organ system = organ failure. Persistence >48 hours = severe AP.

Rosen's EM, Box 77.4

Key Clinical Pearl

"Severity stratification assessments should be performed at 24 hours, 48 hours, and 7 days after admission." - Bailey & Love, 28E

"Persistent SIRS at 24 hours or underlying comorbid illness should prompt consideration of step-down unit care. Patients with higher BISAP scores and elevations in hematocrit and BUN who do not respond to fluid resuscitation and exhibit organ failure should be considered for direct ICU admission." - Harrison's Principles of Internal Medicine, 22E (2025)

References

Harrison's Principles of Internal Medicine, 22E (2025) - BISAP scoring, BUN/hematocrit monitoring, severity triage
Schwartz's Principles of Surgery, 11E - Ranson's criteria (Table 33-7), APACHE II, BISAP, HAPS, SIRS
Sabiston Textbook of Surgery, 21E - Full Ranson criteria (Boxes 92.1/92.2), CTSI (Table 92.2), BISAP, Atlanta classification, SIRS (Box 92.3)
Current Surgical Therapy, 14E - 2012 Atlanta Classification (Table 1), PASS, BISAP, CTSI
Bailey & Love's Short Practice of Surgery, 28E - Ranson & Glasgow comparison (Table 72.3), Atlanta classification, imaging criteria
Rosen's Emergency Medicine - BISAP, Atlanta 2012 (Box 77.4), Modified Marshall Score, MCTSI
Sleisenger & Fordtran's GI and Liver Disease - Balthazar CTSI (Table 58.1), Glasgow/Imrie score, APACHE II, SIRS
Yamada's Textbook of Gastroenterology, 7E - Ranson (Table 74.4), APACHE II (Table 74.5), BISAP
Grainger & Allison's Diagnostic Radiology - Modified CTSI (Table 25.1), CT timing, imaging approach

This is a shared conversation. Sign in to Orris to start your own chat.